Below is a listing of recently published scientific papers authored by our staff.
2024
2023
Health inequities across the lung cancer care continuum in ten marginalized populations: a narrative review. Monestime S, Rigney M, Phipps N, Carlson C, Alongi T, Redding M, et al. Journal of Thoracic Disease. 2023 Nov 30. PMID: 38090306.
Germline EGFR Mutations and Familial Lung Cancer. Oxnard GR, Chen R, Pharr JC, Koeller DR, Bertram AA, Dahlberg SE, Rainville I, Shane-Carson K, Taylor KA, Sable-Hunt A, Sholl LM, Teerlink CC, Thomas A, Cannon-Albright LA, Fay AP, Ashton-Prolla P, Yang H, Salvatore MM, Addario BJ, Jänne PA, Carbone DP, Wiesner GL, Garber JE. J Clin Oncol. 2023 Oct 23:JCO2301372. doi: 10.1200/JCO.23.01372. Epub ahead of print. PMID: 37579253.
Sexual Health Assessment in Women with Lung Cancer study: Sexual health assessment in women with lung cancer. Florez N, Kiel L, Meza K, Wei Z, Mazzola E, Velazquez AI, Franco I, Fidler MJ, Elkins I, Feldman J, Seaborne L, Heisler C, King JC, Moore A, Wiens J, Kushner D. Sexual Health Assessment in Women with Lung Cancer study: Sexual health assessment in women with lung cancer. Cancer. 2023 Oct 16. doi: 10.1002/cncr.35057. PMID: 37843054.
Patient-reported impact of symptoms in lung cancer (PRISM-LC). Varma A, Weinstein J, Seabury J, Rosero S, Zizzi C, Dilek N, Heatwole J, Baumgart M, Mulford D, Maggiore R, Conrow L, King JC, Wiens J, Heatwole C. Patient-reported impact of symptoms in lung cancer (PRISM-LC). Translational Lung Cancer Research. 2023 Jul 7;12(7):1391. PMID: 37577309.
A New Framework for Co-Creating Telehealth for Cancer Care with the Patient Community. Addario B, Astratinei V, Binder L, Geissler J, Horn MK, Krebs LU, Lewis B, Oliver K, Spiegel A. A New Framework for Co-Creating Telehealth for Cancer Care with the Patient Community. Patient. 2023 Jul 26. doi: 10.1007/s40271-023-00642-x. PMID: 37493895.
Leveraging social media to increase lung cancer screening awareness, knowledge and uptake among high-risk populations (The INSPIRE-Lung Study): study protocol of design and methods of a community-based randomized controlled trial. Carter-Bawa L, Banerjee SC, Comer RS, Kale MS, King JC, Leopold KT, Monahan PO, Ostroff JS, Slaven JE Jr, Valenzona F, Wiener RS, Rawl SM. BMC Public Health. 2023 May 26;23(1):975. doi: 10.1186/s12889-023-15857-8.
Influences on Lung Cancer Screening Initiation and Retention in Rural Alabama. Copeland A, Levy K, Hardy CM, King JC, Rigney M. J Prim Care Community Health. 2023 Jan-Dec;14:21501319231168022. doi: 10.1177/21501319231168022.PMID: 37057356
2022
Reducing stigma triggered by assessing smoking status among patients diagnosed with lung cancer: De-stigmatizing do and don’t lessons learned from qualitative interviews. Ostroff JS, Banerjee SC, Lynch K, Shen MJ, Williamson TJ, Haque N, Riley K, Hamann HA, Rigney M, Park B. PEC Innov. 2022 Dec;1:100025. doi: 10.1016/j.pecinn.2022.100025. Epub 2022 Mar 4.
Identifying barriers to lung cancer advocacy: the role of stigma-related interpersonal constraint.
Price SN, Shen M, Rigney M, Ostroff JS, Hamann HA. Oncology Nursing Forum 2022, 49(6), 553-563. doi: 10.1188/22.ONF.553-563
Study protocol of a multiphase optimization strategy trial (MOST) for delivery of smoking cessation treatment in lung cancer screening settings.
Ostroff JS, Shelley DR, Chichester LA, King JC, Li Y, Schofield E, Ciupek A, Criswell A, Acharya R, Banerjee SC, Elkin EB, Lynch K, Weiner BJ, Orlow I, Martin CM, Chan SV, Frederico V, Camille P, Holland S, Kenney J. Study protocol of a multiphase optimization strategy trial (MOST) for delivery of smoking cessation treatment in lung cancer screening settings. Trials. 2022 Aug 17;23(1):664. doi: 10.1186/s13063-022-06568-3. PMID: 35978334; PMCID: PMC9383667.
Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer
Mack PC, Gomez JE, Rodilla AM, Carreño JM, Hsu CY, Rolfo C, Meshulami N, Moore A, Brody RI, King JC, Treatman J, Lee S, Raskin A, Srivastava K, Gleason CR, de Miguel-Perez D; PARIS/PSP study group, Tcheou J, Bielak D, Acharya R, Gerber DE, Rohs N, Henschke CI, Yankelevitz DF, Simon V, Minna JD, Bunn PA Jr, García-Sastre A, Krammer F, Shyr Y, Hirsch FR. Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer. Cancer Cell. 2022 Jun 13;40(6):575-577. doi: 10.1016/j.ccell.2022.04.012. Epub 2022 Apr 20. PMID: 35504289; PMCID: PMC9020481.
Impact of the COVID-19 Pandemic on Global Lung Cancer Clinical Trials: Why it matters to people with lung cancer.
Roy UB, Baird AM, Ciupek A, Fox J, Manley E Jr, Norris K, Scagliotti GV, Wakelee HA, Mitsudomi T, Clark RC, Arndt R, Hirsch FR, Bunn PA, Smeltzer MP. JTO Clin Res Rep. 2022 Feb; 3(2):100269. doi: 10.1016/j.jtocrr.2021.100269.
2021
Lung Cancer and Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Identifying Important Knowledge Gaps for Investigation.
Rolfo C, Meshulami N, Russo A, Krammer F, García-Sastre A, Mack PC, Gomez JE, Bhardwaj N, Benyounes A, Sirera R, Moore A, Rohs N, Henschke CI, Yankelevitz D, King J, Shyr Y, Bunn PA Jr, Minna JD, Hirsch FR.
J Thorac Oncol. 2021 Nov 10:S1556-0864(21)03309-8. doi: 10.1016/j.jtho.2021.11.001.
Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-small Cell Lung Cancer.
Fox AH, Jett JR, Roy UB, Johnson BE, King JC, Martin N, Osarogiagbon RU, Rivera MP, Rosenthal LS, Smith RA, Silvestri GA.
Chest. 2021 Jun 26:S0012-3692(21)01253-8. doi: 10.1016/j.chest.2021.06.027. Online ahead of print.
Oncology Care Provider Training in Empathic Communication Skills to Reduce Lung Cancer Stigma.
Banerjee SC, Haque N, Schofield EA, Williamson TJ, Martin CM, Bylund CL, Shen MJ, Rigney M, Hamann HA, Parker PA, McFarland DC, Park BJ, Molena D, Moreno A, Ostroff JS.
Chest. 2021 May;159(5):2040-2049. doi: 10.1016/j.chest.2020.11.024. Epub 2020 Dec 16.
Responding empathically to patients: a communication skills training module to reduce lung cancer stigma.
Banerjee SC, Haque N, Bylund CL, Shen MJ, Rigney M, Hamann HA, Parker PA, Ostroff JS.
Transl Behav Med. 2021 Mar 16;11(2):613-618. doi: 10.1093/tbm/ibaa011.
The Genomics of Young Lung Cancer: Comprehensive Tissue Genomic Analysis in Patients Under 40 With Lung Cancer.
Gitlitz BJ, Novello S, Vavalà T, Bittoni M, Sable-Hunt A, Pavlick D, Hsu R, Park SL, Chen R, Cooke M, Moore A, Schrock AB, Schiller JH, Addario BJ, Oxnard GR.
JTO Clinical and Research Reports (2021), doi: https://doi.org/10.1016/j.jtocrr.2021.100194
SPACEWALK: A remote participation study of ALK resistance leveraging plasma cell-free DNA genotyping.
Lawrence MN, Tamena RM, Martinez P, Sable-Hunt A, Addario T, Barbour P, Shaffer T, Hosseni SA, Bertucci C, Lim PL, Hong F, Michael K, Simon GR, Reiss JW, Award MM, Oxnard G.
JTO Clinical and Research Reports, 2021, 3 Feb, 100151.
A 10-Year Cross-Sectional Analysis of Public, Oncologist, and Patient Attitudes About Lung Cancer and Associated Stigma.
Rigney M, Rapsomaniki E, Carter-Harris L, King JC.
J Thorac Oncol. 2021 Jan;16(1):151-155. doi: 10.1016/j.jtho.2020.09.011.
2020
Use of a Cancer Registry to Evaluate Patient-Reported Outcomes of Immune Checkpoint Inhibitors.
Jim HSL, Eisel SL, Hoogland AI, Shaw S, King JC, Dicker AP.
Cancers (Basel). 2020 Dec 31;13(1):E103. doi: 10.3390/cancers13010103.
An examination of two dichotomies: Women with lung cancer and living with lung cancer as a chronic disease.
Vavala T, Rigney M, Reale ML, Novello S, King JC.
Respirology. 2020 Oct 29. doi: 10.1111/resp.13965.
Characteristics of Patients With ROS1+ Cancers: Results From the First Patient-Designed, Global, Pan-Cancer ROS1 Data Repository.
Parikh DA, Walia G, Freeman-Daily J, Hennink M, Tomalia T, Buonanno L, Goldman L, Addario B, Patel MI.
JCO Oncol Pract. 2020 Feb;16(2):e183-e189. doi: 10.1200/JOP.19.00135.
The International Association for the Study of Lung Cancer Early Lung Imaging Confederation.
Mulshine JL, Avila RS, Conley E, Devaraj A, Ambrose LF, Flanagan T, Henschke CI, Hirsch FR, Janz R, Kakinuma R, Lam S, McWilliams A, Van Ooijen PMA, Oudkerk M, Pastorino U, Reeves A, Rogalla P, Schmidt H, Sullivan DC, Wind HHJ, Wu N, Wynes M, Xueqian X, Yankelevitz DF, Field JK.
JCO Clin Cancer Inform. 2020 Feb;4:89-99.
2019
Survivor and Caregiver Expectations and Preferences Regarding Lung Cancer Treatment.
Wieland J, Hoppe BS, Rausch-Osian SM, King JC, Sierra A, Hiemenz JW, Bradley J, Pham DC, Jones LM, Yeung AR, Hopper K, Mendenhall NP, Hitchcock KE.
Int J Part Ther. 2019 Fall;6(2):42-49.
Including the patient voice in the development and implementation of patient-reported outcomes in cancer clinical trials.
Addario B, Geissler J, Horn MK, Krebs LU, Maskens D, Oliver K, Plate A, Schwartz E, Willmarth N.
Health Expect. 2019 Nov 13. doi: 10.1111/hex.12997
Improving Molecular Oncology by Making Results Available to Patients.
Oxnard GR, West H, King JC
JAMA Oncol. Epub October 24, 2019. doi:10.1001/jamaoncol.2019.4390
Effectiveness of Lung Cancer Screening Implementation in the Community Setting in the United States.
Copeland A, Criswell A, Ciupek A, King JC.
J Oncol Pract. 2019 Jul;15(7):e607-e615. doi: 10.1200/JOP.18.00788. Epub 2019 May 31.
Updates Regarding Biomarker Testing for Non-Small Cell Lung Cancer: Considerations from the National Lung Cancer Roundtable.
Kim ES, Roy UB, Ersek JL, King J, Smith RA, Martin N, Martins R, Moore A, Silvestri GA, Jett J.
J Thorac Oncol. 2019 Mar;14(3):338-342.
Survivor guilt: The secret burden of lung cancer survivorship.
Perloff T, King JC, Rigney M, Ostroff JS, Shen MJ
J Psychosoc Oncol. 2019 Sep-Oct;37(5):573-585.
2018
The Role of Lung Advocacy Organizations in Biomarker Testing
Aldigé C, Roy U, Boerckel W, Ciupek A, Donaldson D, Grossman H, Langhorne C, Rosenthal LS, Saxton C, Silvestri GA, Smith RA, and Wenger L
White Paper
Geographic Availability of Low-Dose Computed Tomography for Lung Cancer Screening in the United States, 2018.
Eberth JM, Bozorgi P, Lebrón LM, Bills SE, Hazlett LJ, Carlos RC, King JC.
Prev Chronic Dis. 2018 Oct 4;15:E119.
2017
Patient value: Perspectives from the advocacy community
Addario BJ, Fadich A, Fox J, Krebs L, Maskens D, Oliver K, Schwartz E, Spurrier-Bernard G, Turnham T.
Health Expect. 2017 Sept. 20. doi: 10.1111/hex.12628
Patient engagement is mandatory at our table.
Addario BJ, Pritchard D.
Am J Manag Care. 2017 Aug;23(10 Spec No.):SP431-SP432
Decreasing Lung Cancer Mortality through Screening—The Lung Cancer Alliance Experience
Ambrose LF, Copeland A, King JC.
Oncology & Hematology Review, 2017;13(1):17–8
Stigma, self-blame, and satisfaction with care among patients with lung cancer.
Weiss J, Yang H, Weiss S, Rigney M, Copeland A, King JC, Deal AM.
J Psychosoc Oncol. 2017 Mar-Apr;35(2):166-179.
2016
Implementing computed tomography-based lung cancer screening in the community.
Mulshine JL, Ambrose LF.
J Thorac Dis. 2016 Oct;8(10):E1304-E1306.
Planning and Implementation of Low-Dose Computed Tomography Lung Cancer Screening Programs in the United States.
Qiu R, Copeland A, Sercy E, Porter NR, McDonnell KK, Eberth J.
Clin J Oncol Nurs. 2016 Feb;20(1):52-8.
Readiness of Lung Cancer Screening Sites to Deliver Smoking Cessation Treatment: Current Practices, Organizational Priority, and Perceived Barriers.
Ostroff JS, Copeland A, Borderud SP, Li Y, Shelley DR, Henschke CI.
Nicotine Tob Res. 2016 May;18(5):1067-75.
2015
A Qualitative Analysis of “Naturalistic” Conversations in a Peer-Led Online Support Community for Lung Cancer.
Lobchuk M, McClement S, Rigney M, Copeland A, Bayrampour H.
Cancer Nurs. 2015 Sep-Oct;38(5):E21-31.
Lung Cancer Workshop XI: Tobacco-Induced Disease: Advances in Policy, Early Detection and Management.
Mulshine JL, Avila R, Yankelevitz D, Baer TM, Estépar RS, Ambrose LF, Aldigé CR.
J Thorac Oncol. 2015 May;10(5):762-7.
2014
Preventative care: Lung-cancer screens now worth the cost.
Fenton-Ambrose L, Kazerooni EA
Nature. 2014 Oct 2;514(7520):35.
Public attitudes about lung cancer: stigma, support, and predictors of support.
Weiss J, Stephenson BJ, Edwards LJ, Rigney M, Copeland A.
J Multidiscip Healthc. 2014 Jul 16;7:293-300.
.